Loading clinical trials...
Loading clinical trials...
Preliminary Efficacy of a Digital Therapeutics Smartphone Application for Methamphetamine Use Disorder
One hundred participants were recruited and randomized into a digital therapeutics (DTx) group (n=52) and a treatment as usual (TAU) group (n=48). The DTx group used a smartphone application to deliver cognitive behavioral therapy, approach bias modification, cognitive training, and contingency management for eight weeks. The TAU group received counseling from social workers and psychoterapists. Cue-induced craving, cognitive functions, PHQ-9, and GAD-7 were measured at baseline and post-intervention.
Age
18 - 50 years
Sex
ALL
Healthy Volunteers
No
Huangshui Township Municipal Government
Chengdu, Sichuang, China
Start Date
January 1, 2021
Primary Completion Date
March 31, 2021
Completion Date
May 1, 2022
Last Updated
December 2, 2022
100
ACTUAL participants
Cognitive Behavioral Therapy
BEHAVIORAL
Counseling
BEHAVIORAL
Approach Bias Modification
BEHAVIORAL
Cognitive Training
BEHAVIORAL
Lead Sponsor
Adai Technology (Beijing) Co., Ltd.
Collaborators
NCT06233799
NCT04706624
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions